Genpact Awarded Five-Year Contract Extension by GlaxoSmithKline
Posted on January 15, 2013 at 07:11 AM EST
Genpact (NYSE: G ), a global leader in business process management and technology services, today announced it has been awarded a five-year contract extension by global pharmaceutical leader GlaxoSmithKline (NYSE: GSK ) for finance and accounting (F&A) services. Under this agreement, Genpact will continue to deliver global services